【24h】

Blood donor recruitment strategies and their impact on blood safety in Egypt

机译:埃及的献血者招募策略及其对血液安全的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Because of the high incidence of HCV, blood safety presents a serious challenge in Egypt.Given the constrained economy which limits the implementation of nucleic acid amplification technology, proper recruitment of blood donors becomes of paramount importance. To evaluate the effectiveness of blood donor recruitment strategies, the seroprevalence of positive infectious markers among blood donors was studied. Materials and methods: Donors' records covering the period from 2006-2012 were reviewed. Blood donations were screened for HCV antibodies, HBs antigen (HBsAg), HIV-1 and 2 and syphilis antibodies. Results: Of 308,762 donors, 63.4% were voluntary donors (VD). VD of 2011-2012 were significantly younger than family replacement donors (RD). The overall prevalences of HCV antibodies, HBsAg, HIV and syphilis antibodies were 4.3%, 1.22%, 0.07%, and 0.13%, respectively. All tested markers (except HIV) were significantly higher among RD, when compared to VD (P< 0.0001). A consistent steady trend for decrease in HCV seropositivity was observed in RD and VD from 8.9% and 4.2% to 3.8% and 1.5%, respectively. A trend for decrease in HBsAg was demonstrated in VD from 1.2% to 0.53%. Conclusion: The decreasing trends in HCV antibody and HBs antigen is promising and may reflect the improved donor selection criteria.
机译:简介:由于HCV的高发病率,埃及的血液安全面临着严峻的挑战。鉴于经济不景气限制了核酸扩增技术的实施,正确招募献血者变得至关重要。为了评估献血者募集策略的有效性,研究了献血者中阳性感染标记物的血清阳性率。材料和方法:审查了2006年至2012年期间的捐助者记录。对献血者进行了HCV抗体,HBs抗原(HBsAg),HIV-1和2以及梅毒抗体的筛查。结果:在308,762名捐助者中,有63.4%是自愿捐助者(VD)。 2011-2012年的VD明显比家庭替代捐赠者(RD)年轻。 HCV抗体,HBsAg,HIV和梅毒抗体的总体患病率分别为4.3%,1.22%,0.07%和0.13%。与VD相比,RD中所有测试的标志物(HIV除外)均显着更高(P <0.0001)。在RD和VD中观察到HCV血清反应阳性率持续下降的稳定趋势,分别从8.9%和4.2%降至3.8%和1.5%。 VD证实HBsAg降低的趋势从1.2%降至0.53%。结论:HCV抗体和HBs抗原的减少趋势是有希望的,并可能反映出改进的供体选择标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号